Optometry 360
  • Home
  • Conferences
  • Videos
  • About Us
    • About Us – Mission
    • Media Partners
    • Advisory Board
    • Industry Council
    • Business Team

What are you looking for?

  • Conference Roundup
  • Contact Lenses
  • Diagnostics
  • Glaucoma
  • Myopia
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Retina
  • Spotlight Series
The evolving role of the optometrist in nonsurgical cataract management
Optometry 360
  • Home
  • Conferences
  • Videos
  • About Us
    • About Us – Mission
    • Media Partners
    • Advisory Board
    • Industry Council
    • Business Team
Home > Switching myopia-control spectacles may temporarily slow progression in some children
  • Myopia

Switching myopia-control spectacles may temporarily slow progression in some children

Kelsey Moroz

Children with myopia who switched to a different type of myopia-control spectacle experienced a temporary slowing of myopia progression, according to a study.

The retrospective matched-cohort study 1,012 children and adolescents prescribed myopia-control spectacles. Researchers compared 253 participants who switched to a different spectacle type with 759 who continued using the same type after propensity score matching.

Before the switch, children in the change-of-type group had significantly faster myopia progression than those who maintained the same spectacle type. After switching, the progression rate in the change-of-type group slowed significantly, reducing the difference in progression rates between the groups.

However, the benefit was not maintained over time. Researchers found that myopia progression accelerated again during prolonged use of the new spectacle type, with progression rates worsening in the later phase compared with the early phase after switching.

Reference
Zhang J, Pan Q, Jin L, et al. Can switching between different types of myopia control spectacles enhance effectiveness? Findings from a real-world study. Br J Ophthalmol. 2026;bjo-2025-329403. doi: 10.1136/bjo-2025-329403. Epub ahead of print. PMID: 42303290.

Share

Related Content

  • Myopia

Low-dose atropine slowed myopia progression in children with advanced myopia in pilot trial

  • Myopia

Red-light therapy outperforms low-dose atropine in altering macular morphology

  • Myopia

Axial length monitoring may help assess myopia control success in clinical practice

  • Myopia

Thirty minutes of tablet use reduces tear film stability in myopic children

  • Myopia

Height growth timing may inform management of axial elongation in pediatric myopia patients

  • Myopia

MRI-defined eye shape predicts long-term outcomes in high myopia

Share

Advisory Board

Kaleb Abbott, OD, MS, FAAO

Clark Chang, OD

Jessica Haynes, OD, FAAO, FORS, Dipl ABO

Monica Kalia, OD

Cecelia Koetting, OD, FAAO, DipABO

Roya Attar, OD, MBA, DHA, FAAO

Hardeep Kataria, OD, FAAO

Marc R. Bloomenstein, OD, FAAO

Elise Kramer, OD

See All
Optometry 360

Optometry 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

© 2026 Optometry 360 is a trademark of International Healthcare Media, LLC. All rights Reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophthalmology360 Icon